BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB targets 2x the daily returns of the biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV -1.01% 14.41% 41.46% 44.59% 93.99% 35.10% 4.57% 9.35% 18.24% 04/07/2010
BIB Market Price -0.91% 14.69% 41.74% 44.83% 94.28% 35.26% 4.58% 9.38% 18.26% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $102,165,689
  • Gross Expense Ratio
    1.17%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/03/2026
  • NAV
    $118.80
  • NAV Change
    $+1.77 up caret
  • Market Price
    $118.78
  • Market Price Change
    $+1.68 up caret
  • Trading Volume (M)
    5,763
  • 30-Day Median Bid Ask Spread
    0.26%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $102,165,689
  • Gross Expense Ratio
    1.17%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/03/2026
  • NAV
    $118.80
  • NAV Change
    $+1.77 up caret
  • Market Price
    $118.78
  • Market Price Change
    $+1.68 up caret
  • Trading Volume (M)
    5,763
  • 30-Day Median Bid Ask Spread
    0.26%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2027. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2026

Holdings

as of 11/03/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
5.55% GILD GILEAD SCIENCES INC -- $5,673,381.19 33,877 2369174
5.21% AMGN AMGEN INC -- $5,319,250.32 11,532 2023607
4.73% VRTX VERTEX PHARMACEUTICALS INC -- $4,832,039.04 9,104 2931034
3.91% REGN REGENERON PHARMACEUTICALS -- $3,994,669.44 4,104 2730190
3.62% MRNA MODERNA INC -- $3,700,956.44 16,201 BGSXTS3
1.65% RVMD REVOLUTION MEDICINES INC -- $1,689,412.54 8,698 BL71K91
1.46% BIIB BIOGEN INC -- $1,492,584.28 5,996 2455965
1.43% ILMN ILLUMINA INC -- $1,459,750.88 6,128 2613990
1.17% RPRX ROYALTY PHARMA PLC- CL A -- $1,199,781.60 18,069 BMVP7Y0
1.03% ROIV ROIVANT SCIENCES LTD -- $1,056,404.48 29,312 BMW4NZ9
1.02% UTHR UNITED THERAPEUTICS CORP -- $1,046,898.12 1,741 2430412
0.98% ARGX ARGENX SE - ADR -- $997,539.84 1,107 BDVLM39
0.95% INCY INCYTE CORP -- $967,177.75 8,225 2471950
0.93% GH GUARDANT HEALTH INC -- $953,050.00 5,446 BFXC911
0.91% INSM INSMED INC -- $925,547.28 8,862 2614487
0.86% VTRS VIATRIS INC -- $881,861.20 46,610 BMWS3X9
0.85% ALNY ALNYLAM PHARMACEUTICALS INC -- $868,202.70 5,430 B00FWN1
0.74% MEDP MEDPACE HOLDINGS INC -- $751,734.17 1,133 BDCBC61
0.71% EXEL EXELIXIS INC -- $727,077.05 10,055 2576941
0.67% NBIX NEUROCRINE BIOSCIENCES INC -- $680,006.25 4,125 2623911
0.61% ASND ASCENDIS PHARMA A/S -- $624,924.66 2,498 BWXJHM8
0.59% JAZZ JAZZ PHARMACEUTICALS PLC -- $605,135.16 2,634 B4Q5ZN4
0.59% BBIO BRIDGEBIO PHARMA INC -- $602,308.08 8,136 BK1KWG8
0.58% HALO HALOZYME THERAPEUTICS INC -- $592,423.72 4,606 2975098
0.54% TEM TEMPUS AI INC-CL A -- $553,702.60 7,117 BSLSJJ0
0.51% ONC BEONE MEDICINES LTD-ADR -- $516,525.00 1,455 BYYWPW6
0.50% SMMT SUMMIT THERAPEUTICS INC -- $511,493.40 32,373 BMTVQS7
0.43% BMRN BIOMARIN PHARMACEUTICAL INC -- $437,209.30 7,855 2437071
0.42% KYMR KYMERA THERAPEUTICS INC -- $428,801.66 3,374 BMPRZV5
0.40% BNTX BIONTECH SE-ADR -- $408,437.08 4,699 BK6H543
0.39% SNY SANOFI-ADR -- $396,546.84 8,748 2964557
0.37% TWST TWIST BIOSCIENCE CORP -- $377,687.60 2,692 BGKG6G7
0.37% CAI CARIS LIFE SCIENCES INC -- $376,723.80 11,468 BT18HP9
0.36% MDGL MADRIGAL PHARMACEUTICALS INC -- $371,748.16 938 BD59BS7
0.36% PTGX PROTAGONIST THERAPEUTICS INC -- $368,270.24 2,626 BDCBCD8
0.36% PCVX VAXCYTE INC -- $367,231.59 6,039 BKPVGH6
0.36% KRYS KRYSTAL BIOTECH INC -- $366,341.03 1,201 BD6JX35
0.35% IBRX IMMUNITYBIO INC -- $356,536.32 43,008 BNSP0B8
0.35% SYRE SPYRE THERAPEUTICS INC -- $355,188.06 3,578 BQBBDY8
0.34% CYTK CYTOKINETICS INC -- $351,553.02 5,642 BBBSBJ5
0.33% ARWR ARROWHEAD PHARMACEUTICALS IN -- $341,225.96 5,732 BYQBFJ8
0.31% TXG 10X GENOMICS INC-CLASS A -- $318,484.62 4,878 BKS3RS7
0.31% PRAX PRAXIS PRECISION MEDICINES I -- $317,817.83 1,133 BQ721R4
0.30% ALKS ALKERMES PLC -- $311,057.52 6,808 B3P6D26
0.29% AXSM AXSOME THERAPEUTICS INC -- $296,810.86 2,126 BYZR4X4
0.28% AMRX AMNEAL PHARMACEUTICALS INC -- $285,648.14 14,134 BFNF1D6
0.27% IONS IONIS PHARMACEUTICALS INC -- $272,592.48 6,744 BDJ0LS6
0.26% ORKA ORUKA THERAPEUTICS INC -- $267,490.85 2,687 BKVF0J2
0.25% LGND LIGAND PHARMACEUTICALS -- $253,637.68 809 2501578
0.25% GRAL GRAIL INC -- $252,804.72 1,813 BSLSSX7
0.25% KOD KODIAK SCIENCES INC -- $252,169.50 2,550 BFXC933
0.24% IMVT IMMUNOVANT INC -- $243,413.28 8,382 BJRFSB7
0.24% RYTM RHYTHM PHARMACEUTICALS INC -- $241,513.36 2,794 BF2YWG4
0.23% SUPN SUPERNUS INC -- $237,095.40 8,423 BTZRLN8
0.23% PTCT PTC THERAPEUTICS INC -- $230,722.44 3,387 B17VCN9
0.23% CGON CG ONCOLOGY INC -- $230,423.82 3,597 BRBCSP4
0.22% MIRM MIRUM PHARMACEUTICALS INC -- $229,324.05 2,635 BJDX8Y8
0.21% COGT COGENT BIOSCIENCES INC -- $218,724.52 7,042 BLR6XK8
0.21% GMAB GENMAB A/S -SP ADR -- $218,471.20 3,935 BBC9WC7
0.21% SRRK SCHOLAR ROCK HOLDING CORP -- $217,349.16 4,942 BFZQ0L8
0.20% ERAS ERASCA INC -- $207,785.52 14,193 BNLYBF3
0.20% ABVX ABIVAX SA-ADR -- $205,807.20 2,320 BLC89B2
0.19% CRSP CRISPR THERAPEUTICS AG -- $196,160.76 3,924 BDHF4K6
0.18% TVTX TRAVERE THERAPEUTICS INC -- $188,993.25 3,825 BLFGJD5
0.18% KNSA KINIKSA PHARMACEUTICALS INTE -- $182,848.40 1,960 BRXB0C0
0.18% DFTX DEFINIUM THERAPEUTICS INC -- $182,184.73 5,453 BV2DHY6
0.16% ADPT ADAPTIVE BIOTECHNOLOGIES -- $167,080.80 6,476 BJ5FZ74
0.16% EWTX EDGEWISE THERAPEUTICS INC -- $166,055.76 4,407 BKY5JZ8
0.16% VCYT VERACYTE INC -- $164,045.98 3,262 BFTWZY0
0.16% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $163,232.00 5,101 BKX9VD3
0.16% IOVA IOVANCE BIOTHERAPEUTICS INC -- $162,313.06 18,382 BF0DMK7
0.16% ABCL ABCELLERA BIOLOGICS INC -- $160,167.00 13,150 BL53SR3
0.16% TNGX TANGO THERAPEUTICS INC -- $158,529.14 6,842 BP2P6L0
0.15% RLAY RELAY THERAPEUTICS INC -- $155,093.92 8,893 BN2R582
0.15% XENE XENON PHARMACEUTICALS INC -- $150,243.90 3,930 BRJ3GY4
0.15% AMLX AMYLYX PHARMACEUTICALS INC -- $148,715.60 5,093 BPCK358
0.14% ACAD ACADIA PHARMACEUTICALS INC -- $143,825.44 6,992 2713317
0.13% DYN DYNE THERAPEUTICS INC -- $136,782.90 7,578 BN15WD1
0.13% TARS TARSUS PHARMACEUTICALS INC -- $135,546.24 1,866 BMH5RL1
0.13% ELVN ENLIVEN THERAPEUTICS INC -- $133,279.59 2,973 BMFD115
0.12% IRON DISC MEDICINE INC -- $126,447.28 1,558 BMGJZJ8
0.12% DNLI DENALI THERAPEUTICS INC -- $126,172.15 6,487 BD2B4V0
0.12% IDYA IDEAYA BIOSCIENCES INC -- $122,688.28 3,916 BK0VHF6
0.11% BEAM BEAM THERAPEUTICS INC -- $110,349.03 4,191 BK6L288
0.11% NRIX NURIX THERAPEUTICS INC -- $108,728.02 4,211 BMVLGP2
0.11% MBX MBX BIOSCIENCES INC -- $107,470.00 1,954 BQXJKH2
0.10% ADMA ADMA BIOLOGICS INC -- $100,978.79 9,089 B9NSBM2
0.10% PHVS PHARVARIS NV -- $99,088.22 2,849 BMZ2X38
0.09% -- NEWAMSTERDAM PHARMA CO NV -- $96,534.90 4,851 BP8JSP4
0.09% XNCR XENCOR INC -- $92,440.88 3,017 BGCYWN8
0.09% VERA VERA THERAPEUTICS INC -- $89,796.04 2,924 BL55460
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $89,407.44 5,399 BFWLC09
0.09% BCRX BIOCRYST PHARMACEUTICALS INC -- $88,870.90 10,370 2100362
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $87,478.26 2,363 BKSGZN7
0.08% ZYME ZYMEWORKS INC -- $86,774.40 2,880 BPCQZY9
0.08% VCEL VERICEL CORP -- $85,385.02 2,078 BSBMN89
0.08% SEPN SEPTERNA INC -- $82,767.80 1,894 BQNKXX2
0.08% FTRE FORTREA HOLDINGS INC -- $80,846.05 3,859 BRXYZ57
0.08% LEGN LEGEND BIOTECH CORP-ADR -- $80,292.24 3,738 BMX9K07
0.08% TRVI TREVI THERAPEUTICS INC -- $80,138.52 5,782 BJH9ZN0
0.08% RXRX RECURSION PHARMACEUTICALS-A -- $79,944.32 21,724 BM9FJ13
0.08% SRPT SAREPTA THERAPEUTICS INC -- $79,462.44 4,286 B8DPDT7
0.08% REPL REPLIMUNE GROUP INC -- $78,944.95 3,823 BDDVW37
0.08% VIR VIR BIOTECHNOLOGY INC -- $77,047.74 6,867 BK4PZ38
0.07% XERS XERIS BIOPHARMA HOLDINGS INC -- $76,579.65 7,399 BLR7H87
0.07% PGEN PRECIGEN INC -- $76,277.25 14,529 BKM5C84
0.07% AGIO AGIOS PHARMACEUTICALS INC -- $75,597.60 2,423 BCBVTX1
0.07% ZBIO ZENAS BIOPHARMA INC -- $75,065.10 2,645 BQB42H3
0.07% MAZE MAZE THERAPEUTICS INC -- $72,691.50 2,254 BSRK699
0.07% STOK STOKE THERAPEUTICS INC -- $70,659.82 2,618 BJQ05Z6
0.07% ABSI ABSCI CORP -- $69,640.00 6,964 BN94K69
0.07% PSNL PERSONALIS INC -- $68,260.50 4,334 BJQ0608
0.07% URGN UROGEN PHARMA LTD -- $68,249.60 1,984 BZ7PJQ1
0.07% GPCR STRUCTURE THERAPEUTICS INC -- $67,684.10 3,326 BQS9486
0.07% NTLA INTELLIA THERAPEUTICS INC -- $67,435.96 5,686 BYZM6C2
0.07% ANIP ANI PHARMACEUTICALS INC -- $67,364.96 932 BCDWBX6
0.07% QURE UNIQURE NV -- $67,194.05 2,815 BJFSR88
0.07% TRAX FIRST TRACKS BIOTHERAPEUTICS -- $67,193.00 1,450 BS2CR64
0.07% RARE ULTRAGENYX PHARMACEUTICAL IN -- $66,536.63 4,001 BJ62Z18
0.06% NVAX NOVAVAX INC -- $64,788.24 6,693 BJDQXG4
0.06% NVCR NOVOCURE LTD -- $63,456.75 4,725 BYSS4X4
0.06% ALVO ALVOTECH SA -- $62,311.50 13,725 BPNTJ34
0.06% INVA INNOVIVA INC -- $61,366.76 2,932 BDDXF67
0.06% OCUL OCULAR THERAPEUTIX INC -- $60,779.84 8,912 BNZB1X8
0.06% ETON ETON PHARMACEUTICALS INC -- $59,102.00 1,160 BGL0JK3
0.06% PCRX PACIRA BIOSCIENCES INC -- $58,879.02 1,618 B3X26D8
0.06% MLYS MINERALYS THERAPEUTICS INC -- $57,372.12 3,588 BP9N0G0
0.06% ANAB ANAPTYSBIO INC -- $57,371.46 1,202 BDRW1L7
0.06% GHRS GH RESEARCH PLC -- $56,500.08 2,786 BP6C0S2
0.06% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $56,456.40 1,880 BLCD809
0.05% TSHA TAYSHA GENE THERAPIES INC -- $54,077.98 13,222 BNC1BX1
0.05% OMER OMEROS CORP -- $53,677.26 2,938 B4NB858
0.05% SNDX SYNDAX PHARMACEUTICALS INC -- $51,786.96 3,624 BN7Q7R7
0.05% TYRA TYRA BIOSCIENCES INC -- $51,758.14 2,422 BMVNDH9
0.05% RAPP RAPPORT THERAPEUTICS INC -- $49,531.68 1,947 BR3T9B6
0.05% MNKD MANNKIND CORP -- $48,669.04 13,048 BF081J4
0.05% INBX INHIBRX BIOSCIENCES INC -- $48,404.76 597 BNSP8K3
0.05% VOR VOR BIOPHARMA INC -- $47,683.86 2,401 BRJJYT3
0.05% AMPH AMPHASTAR PHARMACEUTICALS IN -- $46,809.12 1,726 BNFWZS4
0.05% CMPS COMPASS PATHWAYS PLC -- $46,678.06 5,434 BMC3HS7
0.04% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $45,042.70 6,046 BMCWKZ2
0.04% JANX JANUX THERAPEUTICS INC -- $44,211.42 2,481 BMFX8Y7
0.04% CSTL CASTLE BIOSCIENCES INC -- $43,573.60 1,240 BKLCWZ3
0.04% HROW HARROW INC -- $43,409.34 1,521 BHNDW86
0.04% CGEM CULLINAN THERAPEUTICS INC -- $41,139.00 2,612 BM90J52
0.04% ORIC ORIC PHARMACEUTICALS INC -- $40,335.54 4,206 BKVDFF7
0.04% ZLAB ZAI LAB LTD-ADR -- $39,703.68 1,808 BD9GVY0
0.04% SVRA SAVARA INC -- $39,605.50 8,338 BYXGN81
0.04% SLN SILENCE THERAPEUTICS PLC-ADR -- $37,720.46 1,907 BL5B6Z1
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $37,099.44 3,897 BFYQFJ2
0.04% RIGL RIGEL PHARMACEUTICALS INC -- $37,035.88 758 BQD3J33
0.04% GLUE MONTE ROSA THERAPEUTICS INC -- $36,039.42 3,462 BP7KZP7
0.03% KURA KURA ONCOLOGY INC -- $35,666.80 3,610 BYZD465
0.03% ALMS ALUMIS INC -- $34,138.00 5,252 BPLQG36
0.03% CRVS CORVUS PHARMACEUTICALS INC -- $33,559.62 3,414 BYP80F1
0.03% PRME PRIME MEDICINE INC -- $33,488.00 7,360 BPBJFM7
0.03% ANNX ANNEXON INC -- $32,233.67 7,693 BMVV9R5
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $32,228.40 856 BL95N25
0.03% MESO MESOBLAST LTD- SPON ADR -- $31,430.56 2,128 BQS7491
0.03% COLL COLLEGIUM PHARMACEUTICAL INC -- $31,347.33 1,321 BX7RSN3
0.03% ABUS ARBUTUS BIOPHARMA CORP -- $31,152.52 8,029 BZ0QMB7
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $30,778.16 12,614 B4N8MH9
0.03% ARDX ARDELYX INC -- $30,639.36 10,112 BN89V40
0.03% OABI OMNIAB INC -- $30,385.00 5,900 BN13S71
0.03% SANA SANA BIOTECHNOLOGY INC -- $29,641.12 12,148 BMFJJ97
0.03% WVE WAVE LIFE SCIENCES INC -- $28,625.68 7,996 C08GM13
0.03% CADL CANDEL THERAPEUTICS INC -- $27,386.10 3,105 BP0TQC5
0.03% SLDB SOLID BIOSCIENCES INC -- $27,324.28 4,351 BQHN6C7
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $26,791.90 2,242 BKLXFX5
0.03% DSGN DESIGN THERAPEUTICS INC -- $26,263.60 2,540 BMFK3H6
0.03% AURA AURA BIOSCIENCES INC -- $26,257.92 4,208 BP81R42
0.03% OLMA OLEMA PHARMACEUTICALS INC -- $26,099.85 3,551 BMZ4LN0
0.03% AVBP ARRIVENT BIOPHARMA INC -- $26,053.02 2,001 BMGTLY5
0.02% SGMT SAGIMET BIOSCIENCES INC-A -- $24,865.05 2,499 BP2NYN2
0.02% ZVRA ZEVRA THERAPEUTICS INC -- $24,726.60 2,410 BLFBZ32
0.02% GERN GERON CORP -- $24,246.96 26,072 2370381
0.02% BCAX BICARA THERAPEUTICS INC -- $24,057.60 2,685 BQB42F1
0.02% IRWD IRONWOOD PHARMACEUTICALS INC -- $23,467.50 6,705 B3MZ6K5
0.02% ACRS ACLARIS THERAPEUTICS INC -- $22,339.02 5,973 BYV2W40
0.02% NGNE NEUROGENE INC -- $21,656.04 812 BS2F741
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $21,410.90 2,095 B7F2TY6
0.02% RGNX REGENXBIO INC -- $20,440.77 2,679 BZ0G875
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $19,760.84 5,093 BYVQJ96
0.02% EOLS EVOLUS INC -- $19,751.60 2,680 BDRJH21
0.02% LKFT LAKEFRONT BIOTHERAPEUTIC-ADR -- $19,418.60 604 B292NQ7
0.02% CTMX CYTOMX THERAPEUTICS INC -- $19,275.56 8,842 BYWVTY5
0.02% PHAT PHATHOM PHARMACEUTICALS INC -- $18,844.42 3,283 BJLKVS6
0.02% ARVN ARVINAS INC -- $18,809.77 2,653 BDZ30Q0
0.02% CRMD CORMEDIX INC -- $17,586.28 3,163 BJ0LT31
0.02% PRTA PROTHENA CORP PLC -- $17,101.43 2,083 B91XRN2
0.02% KMDA KAMADA LTD -- $16,972.25 2,341 B2Q9833
0.02% EDIT EDITAS MEDICINE INC -- $16,203.20 6,232 BZ8FPH3
0.02% ALT ALTIMMUNE INC -- $16,103.76 7,894 BFY7DC4
0.02% CCCC C4 THERAPEUTICS INC -- $16,024.32 4,992 BKX9NQ0
0.02% TKNO ALPHA TEKNOVA INC -- $15,993.86 2,179 BP7L561
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $15,702.40 14,020 BFZNYB7
0.01% TECX TECTONIC THERAPEUTIC INC -- $15,051.14 793 BPBPCG8
0.01% AVIR ATEA PHARMACEUTICALS INC -- $13,573.35 3,255 BLN9Z50
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $13,560.84 2,439 BPRB2N7
0.01% CTNM CONTINEUM THERAPEUTICS INC-A -- $12,955.53 1,337 BPRBTY7
0.01% KYTX KYVERNA THERAPEUTICS INC -- $12,951.60 2,510 BSMLR16
0.01% SPRY ARS PHARMACEUTICALS INC -- $12,309.80 4,036 BMCR7V2
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $12,257.34 1,182 B9L5200
0.01% FULC FULCRUM THERAPEUTICS INC -- $11,579.04 3,096 BJDX8Z9
0.01% AUTL AUTOLUS THERAPEUTICS PLC -- $11,518.10 8,140 BFMLGR4
0.01% RCKT ROCKET PHARMACEUTICALS INC -- $11,182.05 4,455 BDFKQ07
0.01% BIOA BIOAGE LABS INC -- $11,097.52 1,862 BT9K6D8
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $10,999.62 1,153 BKC9SX3
0.01% LRMR LARIMAR THERAPEUTICS INC -- $10,708.64 4,216 BMXNGZ6
0.01% LYEL LYELL IMMUNOPHARMA INC -- $10,705.38 994 BTNMG41
0.01% QSI QUANTUM-SI INC -- $10,494.90 8,073 BNR5QT9
0.01% LXEO LEXEO THERAPEUTICS INC -- $10,353.19 3,329 BQ6C357
0.01% LFCR LIFECORE BIOMEDICAL INC -- $9,861.12 1,536 2517058
0.01% CABA CABALETTA BIO INC -- $9,769.60 6,880 BK5MWR1
0.01% IMRX IMMUNEERING CORP - CLASS A -- $9,660.00 2,625 BMVBZF5
0.01% VNDA VANDA PHARMACEUTICALS INC -- $9,202.50 2,454 B12W3P6
0.01% SIGA SIGA TECHNOLOGIES INC -- $9,068.76 2,916 2107437
0.01% KROS KEROS THERAPEUTICS INC -- $8,718.15 805 BM7V485
0.01% ACIU AC IMMUNE SA -- $8,631.70 4,130 BZC0D70
0.01% UPB UPSTREAM BIO INC -- $7,535.97 2,223 BRCFFK6
0.01% TRDA ENTRADA THERAPEUTICS INC -- $7,457.60 1,580 BP81RK8
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $6,958.32 1,896 BKDQKM6
0.01% IVVD INVIVYD INC -- $6,955.32 11,961 BM8NHS1
0.01% PEPG PEPGEN INC -- $6,915.06 2,811 BMTX3D7
0.01% SION SIONNA THERAPEUTICS INC -- $6,697.75 1,835 BQKXDX4
0.01% PYXS PYXIS ONCOLOGY INC -- $5,551.40 3,385 BLBR8D5
0.01% MENS JYONG BIOTECH LTD -- $5,491.30 3,085 BPTK6Z2
0.01% FHTX FOGHORN THERAPEUTICS INC -- $5,133.30 2,410 BMF7DT9
-- CHRS COHERUS ONCOLOGY INC -- $5,051.11 6,270 BRK0149
-- HUMA HUMACYTE INC -- $4,965.76 11,273 BMYTJP4
-- CDXS CODEXIS INC -- $4,799.52 4,444 B5LL2C2
-- NBP NOVABRIDGE BIOSCIENCES -- $4,600.55 4,555 BKRRKY7
-- VYGR VOYAGER THERAPEUTICS INC -- $4,575.00 2,500 BY7RB53
-- AVXL ANAVEX LIFE SCIENCES CORP -- $4,514.40 3,762 BYTYP72
-- LENZ LENZ THERAPEUTICS INC -- $4,462.50 1,275 BQV0J03
-- NMRA NEUMORA THERAPEUTICS INC -- $4,353.11 7,625 BN4JN37
-- BDTX BLACK DIAMOND THERAPEUTICS I -- $4,219.11 2,331 BKTV702
-- TNYA TENAYA THERAPEUTICS INC -- $3,278.37 9,099 BNNXX52
-- RANI RANI THERAPEUTICS HOLDINGS-A -- $2,603.37 4,684 BNNXX18
-- GOSS GOSSAMER BIO INC -- $2,301.44 248 C0BCTT5
-- CRBU CARIBOU BIOSCIENCES INC -- $1,998.39 4,350 BNYJR68
-- EYPT EYEPOINT INC -- $1,398.85 3,498 BMGS7L1
-- AARD AARDVARK THERAPEUTICS INC -- $1,092.24 888 BTXQTX3
-- -- COHERUS ONCOLOGY INC COMMON STOCK USD -- $00.00 5,356 --
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
33.13% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 33,847,031 -- 4,658 --
32.82% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 33,534,574 -- 4,615 --
31.00% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 31,667,102 -- 4,358 --
18.77% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 19,176,109 -- 2,639 --
17.87% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 18,260,539 -- 2,513 --
4.47% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 4,570,584 -- 629 --
-- IQMM PROSHARES GENIUS MONEY MARKET ETF -- $17,013,600.00 170,000 BTGTPK8
-- -- NET OTHER ASSETS (LIABILITIES) -- $22,006,134.40 22,006,134 --

Index

as of 9/30/2026

  • Total Number of Holdings245
  • Price/Book Ratio6.08
  • Dividend Yield ( % )0.49
  • Avg. Index Market Capitalization$7.91 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.